991 related articles for article (PubMed ID: 10326160)
1. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
Sadoul N; de Chillou C; Aliot E; McKenna WJ
Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
Pokorski RJ
J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
[TBL] [Abstract][Full Text] [Related]
4. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
[TBL] [Abstract][Full Text] [Related]
6. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
[TBL] [Abstract][Full Text] [Related]
8. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up.
Dimitrow PP; Chojnowska L; Rudzinski T; Piotrowski W; Ziólkowska L; Wojtarowicz A; Wycisk A; Dabrowska-Kugacka A; Nowalany-Kozielska E; Sobkowicz B; Wróbel W; Aleszewicz-Baranowska J; Rynkiewicz A; Loboz-Grudzien K; Marchel M; Wysokinski A
Eur Heart J; 2010 Dec; 31(24):3084-93. PubMed ID: 20843960
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
10. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
Brito D; Madeira H
Rev Port Cardiol; 2005 Sep; 24(9):1137-46. PubMed ID: 16335287
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
Miller MA; Gomes JA; Fuster V
Nat Clin Pract Cardiovasc Med; 2007 Dec; 4(12):667-76. PubMed ID: 18033231
[TBL] [Abstract][Full Text] [Related]
12. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
Cotiga D; Ehlert F; Sherrid M
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
[TBL] [Abstract][Full Text] [Related]
13. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
15. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
[TBL] [Abstract][Full Text] [Related]
17. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
Domal-Kwiatkowska D; Smolik S; Mazurek U; Moric E; Polońska J; Nowalany-Kozielska E; Glanowska G; Wodniecki J; Szarek J; Wilczewski P; Kozakiewicz K; Tendera M; Wilczok T
Wiad Lek; 2000; 53(1-2):4-21. PubMed ID: 10806915
[TBL] [Abstract][Full Text] [Related]
18. Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
[TBL] [Abstract][Full Text] [Related]
19. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
McKenna WJ; Kleinebenne A
Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]